Cargando…

Alternative Calculations of Individual Patient Time in Therapeutic Range While Taking Warfarin: Results From the ROCKET AF Trial

BACKGROUND: In the ROCKET AF (Rivaroxaban–Once‐daily, oral, direct Factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation) trial, marked regional differences in control of warfarin anticoagulation, measured as the average individual...

Descripción completa

Detalles Bibliográficos
Autores principales:	Singer, Daniel E., Hellkamp, Anne S., Yuan, Zhong, Lokhnygina, Yuliya, Patel, Manesh R., Piccini, Jonathan P., Hankey, Graeme J., Breithardt, Günter, Halperin, Jonathan L., Becker, Richard C., Hacke, Werner, Nessel, Christopher C., Mahaffey, Kenneth W., Fox, Keith A. A., Califf, Robert M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4392426/ https://www.ncbi.nlm.nih.gov/pubmed/25736441 http://dx.doi.org/10.1161/JAHA.114.001349

Ejemplares similares

Impact of Global Geographic Region on Time in Therapeutic Range on Warfarin Anticoagulant Therapy: Data From the ROCKET AF Clinical Trial
por: Singer, Daniel E., et al.
Publicado: (2013)

Relationship Between Time in Therapeutic Range and Comparative Treatment Effect of Rivaroxaban and Warfarin: Results From the ROCKET AF Trial
por: Piccini, Jonathan P., et al.
Publicado: (2014)

Clinical characteristics and outcomes with rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trial
por: Breithardt, Günter, et al.
Publicado: (2014)

Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF Trial
por: Steinberg, Benjamin A., et al.
Publicado: (2015)

Hospitalizations in patients with atrial fibrillation: an analysis from ROCKET AF
por: DeVore, Adam D., et al.
Publicado: (2016)

Termination Based on Event Accrual in Per Protocol Versus Intention to Treat in the ROCKET AF Trial
por: Carnicelli, Anthony P., et al.
Publicado: (2021)

Pharmacotherapy for diabetes and stroke risk: Results from ROCKET AF
por: Ugowe, Francis E., et al.
Publicado: (2021)

Safety and Efficacy of Rivaroxaban in Patients With Cardiac Implantable Electronic Devices: Observations From the ROCKET AF Trial
por: Leef, George C., et al.
Publicado: (2017)

Patient-Reported Satisfaction and Study Drug Discontinuation: Post-Hoc Analysis of Findings from ROCKET AF
por: Ungar, Leo, et al.
Publicado: (2019)

Native valve disease in patients with non-valvular atrial fibrillation on warfarin or rivaroxaban
por: Breithardt, Günter, et al.
Publicado: (2016)

Selective Serotonin Reuptake Inhibitors and Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation: An Analysis From the ROCKET AF Trial
por: Quinn, Gene R., et al.
Publicado: (2018)

Comparisons of Rivaroxaban Following Different Dosage Criteria (ROCKET AF or J‐ROCKET AF Trials) in Asian Patients With Atrial Fibrillation
por: Chan, Yi‐Hsin, et al.
Publicado: (2019)

Comparison of Patient‐Reported Care Satisfaction, Quality of Warfarin Therapy, and Outcomes of Atrial Fibrillation: Findings From the ORBIT‐AF Registry
por: Perino, Alexander C., et al.
Publicado: (2019)

Management of acute stroke in patients taking novel oral anticoagulants
por: Hankey, Graeme J, et al.
Publicado: (2014)

ROCKET AF adds more concerns about Digoxin safety in patients with atrial fibrillation
por: ElMaghawry, Mohamed
Publicado: (2015)

Net Clinical Benefit of Left Atrial Appendage Closure Versus Warfarin in Patients With Atrial Fibrillation: A Pooled Analysis of the Randomized PROTECT‐AF and PREVAIL Studies
por: Brouwer, Tom F., et al.
Publicado: (2019)

Early therapeutic persistence on dabigatran versus warfarin therapy in patients with atrial fibrillation: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry
por: Jackson, Larry R., et al.
Publicado: (2018)

Increased Heart Rate Is Associated With Higher Mortality in Patients With Atrial Fibrillation (AF): Results From the Outcomes Registry for Better Informed Treatment of AF (ORBIT-AF)
por: Steinberg, Benjamin A, et al.
Publicado: (2015)

Predictors of intracranial hemorrhage in patients with atrial fibrillation treated with oral anticoagulants: Insights from the GARFIELD‐AF and ORBIT‐AF registries
por: Lim, Toon Wei, et al.
Publicado: (2023)

Cause of Death and Predictors of All‐Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF
por: Pokorney, Sean D., et al.
Publicado: (2016)

Make : Rockets : down-to-earth rocket science
por: Westerfield, Mike
Publicado: (2014)

Rocketing into the future: the history and technology of rocket planes
por: van Pelt, Michel
Publicado: (2012)

It is rocket science, then
por: Cookson, C
Publicado: (2003)

Rockets and missiles
por: Taylor, John W R
Publicado: (1970)

Efficacy and safety of NOAC versus warfarin in AF patients with left atrial enlargement
por: Wu, Victor Chien-Chia, et al.
Publicado: (2020)

Prevalence, Characteristics, and Outcomes of Valvular Heart Disease in Patients With Atrial Fibrillation: Insights From the ORBIT‐AF (Outcomes Registry for Better Informed Treatment for Atrial Fibrillation)
por: Thomas, Kevin L., et al.
Publicado: (2017)

The flight of uncontrolled rockets
por: Gantmakher, F R, et al.
Publicado: (1964)

Materials for rockets and missiles
por: Frank, Robert G, et al.
Publicado: (1959)

Provider Specialty and Atrial Fibrillation Treatment Strategies in United States Community Practice: Findings From the ORBIT‐AF Registry
por: Fosbol, Emil L., et al.
Publicado: (2013)

Pharmacotherapy for Atrial Fibrillation in Patients With Chronic Kidney Disease: Insights From ORBIT‐AF
por: Washam, Jeffrey B., et al.
Publicado: (2018)

NOACs versus warfarin for stroke prevention in patients with AF: a systematic review and meta-analysis
por: Hicks, Tim, et al.
Publicado: (2016)

Experimental validation of rotating detonation for rocket propulsion
por: Bennewitz, John W., et al.
Publicado: (2023)

Atrial fibrillation bleeding risk and prediction while treated with direct oral anticoagulants in warfarin‐naïve or warfarin‐experienced patients
por: Perino, Alexander C., et al.
Publicado: (2022)

Nuclear Rocket Engine Reactor
por: Lanin, Anatoly
Publicado: (2013)

Fundamentals of aircraft and rocket propulsion
por: El-Sayed, Ahmed F
Publicado: (2016)

Stroke Risk and Treatment in Patients with Atrial Fibrillation and Low CHA(2)DS(2)‐VASc Scores: Findings From the ORBIT‐AF I and II Registries
por: Jackson, Larry R., et al.
Publicado: (2018)

Rocket ranch: the nuts and bolts of the Apollo Moon program at Kennedy Space Center
por: Ward, Jonathan H
Publicado: (2015)

Therapeutic Strategies Following Major, Clinically Relevant Nonmajor, and Nuisance Bleeding in Atrial Fibrillation: Findings From ORBIT‐AF
por: O'Brien, Emily C., et al.
Publicado: (2018)

Clinical Characteristics, Oral Anticoagulation Patterns, and Outcomes of Medicaid Patients With Atrial Fibrillation: Insights From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT‐AF I) Registry
por: O'Brien, Emily C., et al.
Publicado: (2016)

History of liquid propellant rocket engines
por: Sutton, George P
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_g4qtqruhsjqp3ivnji0l8rutrh